ES2132645T3 - Uso en una composicion farmaceutica. - Google Patents

Uso en una composicion farmaceutica.

Info

Publication number
ES2132645T3
ES2132645T3 ES95910179T ES95910179T ES2132645T3 ES 2132645 T3 ES2132645 T3 ES 2132645T3 ES 95910179 T ES95910179 T ES 95910179T ES 95910179 T ES95910179 T ES 95910179T ES 2132645 T3 ES2132645 T3 ES 2132645T3
Authority
ES
Spain
Prior art keywords
administration
pharmaceutical composition
freees
antiprogestin
dub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95910179T
Other languages
English (en)
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical College of Hampton Roads
Original Assignee
Medical College of Hampton Roads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical College of Hampton Roads filed Critical Medical College of Hampton Roads
Application granted granted Critical
Publication of ES2132645T3 publication Critical patent/ES2132645T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

METODO PARA TRATAR UNA AFECCION DEPENDIENTE DE LOS ESTROGENOS OVARICOS TAL COMO LA ENDOMETRIOSIS, LEIOMYOMATA UTERINA, PMS, O DUB, QUE SUPONE LA ADMINISTRACION DE UNA GONADOTROPINA QUE LIBERA ANALOGO DE HORMONA Y LA ADMINISTRACION DE ANTIPROGESTINA, QUE FACILITARAN UN METODO TERAPEUTICO PARA UN TRATAMIENTO DE LARGA DURACION SIN UNA PERDIDA RAPIDA DE DENSIDAD OSEA, COMO SE PRODUCE UTILIZANDO ANALOGOS GNRH UNICAMENTE.
ES95910179T 1994-02-04 1995-02-02 Uso en una composicion farmaceutica. Expired - Lifetime ES2132645T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number Publication Date
ES2132645T3 true ES2132645T3 (es) 1999-08-16

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95910179T Expired - Lifetime ES2132645T3 (es) 1994-02-04 1995-02-02 Uso en una composicion farmaceutica.

Country Status (29)

Country Link
US (1) US5681817A (es)
EP (1) EP0785792B1 (es)
JP (1) JP3130048B2 (es)
KR (1) KR970700507A (es)
CN (1) CN1144486A (es)
AP (1) AP724A (es)
AT (1) ATE179610T1 (es)
AU (1) AU689229B2 (es)
BG (1) BG62238B1 (es)
BR (1) BR9506606A (es)
CA (1) CA2182183C (es)
CZ (1) CZ291709B6 (es)
DE (1) DE69509544T2 (es)
DK (1) DK0785792T3 (es)
ES (1) ES2132645T3 (es)
FI (1) FI963036A0 (es)
GR (1) GR3030164T3 (es)
HU (1) HUT74622A (es)
LT (1) LT4182B (es)
LV (1) LV11782B (es)
MD (1) MD1432C2 (es)
NZ (1) NZ281441A (es)
OA (1) OA10777A (es)
PL (1) PL178273B1 (es)
RO (1) RO117420B1 (es)
RU (1) RU2110274C1 (es)
SK (1) SK96296A3 (es)
TJ (1) TJ242B (es)
WO (1) WO1995020972A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003138A1 (en) * 1994-07-22 1996-02-08 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6274573B1 (en) 1997-10-17 2001-08-14 Mochida Pharmaceutical Co., Ltd. Method of treatment for uterine leiomyoma
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
DE60036723T2 (de) * 1999-08-31 2008-07-17 Bayer Schering Pharma Aktiengesellschaft Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
BR0115067A (pt) * 2000-10-30 2004-04-06 Univ Zuerich Análogos de gnrh para tratamento de incontinência urinária
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
EP2316441A1 (en) * 2005-02-17 2011-05-04 Hadasit Medical Research Services And Development Bisphosphonates for treating endometriosis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
MX2009003953A (es) * 2006-10-24 2009-04-28 Repros Therapeutics Inc Composicones y metodos para suprimir la proliferacion endometrial.
WO2008144143A1 (en) * 2007-05-14 2008-11-27 Drugtech Corporation Endometriosis treatment
US20110208118A1 (en) * 2007-09-20 2011-08-25 Bio-Pro Medical Ltd. Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endometriosis, adenomyosis and related disorders by mifepristone
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
KR101585221B1 (ko) 2014-02-27 2016-01-13 권희완 지압대 겸용 지압 베개
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3879031T2 (de) 1987-08-08 1993-06-24 Akzo Nv Kontrazeptives implantat.
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
JP3112172B2 (ja) 1990-03-16 2000-11-27 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ ベノートスハップ 多嚢胞卵巣疾病の治療
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
LT4182B (en) 1997-06-25
DE69509544D1 (de) 1999-06-10
ATE179610T1 (de) 1999-05-15
CA2182183A1 (en) 1995-08-10
BG62238B1 (bg) 1999-06-30
PL178273B1 (pl) 2000-03-31
KR970700507A (ko) 1997-02-12
AU689229B2 (en) 1998-03-26
EP0785792B1 (en) 1999-05-06
EP0785792A4 (es) 1997-07-30
DK0785792T3 (da) 1999-10-18
US5681817A (en) 1997-10-28
MD1432B2 (en) 2000-03-31
GR3030164T3 (en) 1999-08-31
MD1432C2 (ro) 2000-09-30
BG100766A (en) 1997-06-30
AP9600840A0 (en) 1996-07-31
FI963036A (fi) 1996-08-01
WO1995020972A1 (en) 1995-08-10
TJ242B (en) 1999-11-24
JP3130048B2 (ja) 2001-01-31
RU2110274C1 (ru) 1998-05-10
BR9506606A (pt) 1997-09-09
FI963036A0 (fi) 1996-08-01
HU9601969D0 (en) 1996-09-30
EP0785792A1 (en) 1997-07-30
LV11782B (en) 1997-12-20
PL315792A1 (en) 1996-12-09
JPH09508418A (ja) 1997-08-26
NZ281441A (en) 1999-09-29
AP724A (en) 1999-01-18
HUT74622A (en) 1997-01-28
AU1838695A (en) 1995-08-21
LV11782A (lv) 1997-06-20
RO117420B1 (ro) 2002-03-29
CZ291709B6 (cs) 2003-05-14
CA2182183C (en) 2003-09-16
SK96296A3 (en) 1997-07-09
LT96133A (en) 1997-01-27
DE69509544T2 (de) 1999-09-02
CZ210396A3 (en) 1997-05-14
OA10777A (en) 2002-12-23
CN1144486A (zh) 1997-03-05

Similar Documents

Publication Publication Date Title
ES2132645T3 (es) Uso en una composicion farmaceutica.
MX9101784A (es) Formulaciones,metodos y dispositivos anticonceptivos transdermicos
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
TR199801679T2 (xx) Osteoporoz i�in birle�tirme terapisi.
ES2186517B2 (es) Formulacion farmaceutica que contiene fulvestrant.
EA200201000A1 (ru) Гормон-заместительная терапия
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
ATE217192T1 (de) Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen
PT748190E (pt) Metodos e formulacoes para uso no tratamento de disturbios ginecologicos benignos
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
DK1112075T3 (da) Præparater til behandling af mandlig erektil dysfunktion
TR199700930T2 (xx) Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit.
DK0772441T3 (da) Progesteronantagonist og gestagen til behandling af endometriose og leiomyomata
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
TR200100234T2 (tr) Biyojen estrojensülfamatların hormon sübstitüsyon terapisinde kullanılması.
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
DE69803773T2 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
PT1082129E (pt) Metodo para o tratamento de disturbios da fertilidade
NO985573L (no) Veksthormonkomponent og ben-antiresorpsjonsmiddel ved syklisk (koherens-) behandling av osteoporose
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
AR027287A1 (es) Gonadotrofina
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
AR024438A1 (es) Antagonista hormonal liberador de gonadotropina
AR002283A1 (es) Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 785792

Country of ref document: ES